Sequences diagnostic for shrimp pathogens
View Patent ↗Primers have been isolated that are diagnostic for the detection of the taura syndrome virus (TSV). The primers are based on a new portion of the TSV genome and may be used in primer directed amplification or nucleic acid hybridization assay methods.
1. An isolated TSV diagnostic primer sequence consisting of SEQ ID NO:1 or an isolated nucleic acid molecule that is completely complementary to SEQ ID NO:1.
2. An isolated TSV diagnostic primer sequence consisting of SEQ ID NO:2 or an isolated nucleic acid molecule that is completely complementary to SEQ ID NO:2.
3. An isolated TSV diagnostic primer sequence consisting of SEQ ID NO:3 or an isolated nucleic acid molecule that is completely complementary to SEQ ID NO:3.
4. An isolated TSV diagnostic primer sequence consisting of SEQ ID NO:4 or an isolated nucleic acid molecule that is completely complementary to SEQ ID NO:4.
5. An isolated TSV diagnostic primer sequence consisting of SEQ ID NO:5 or an isolated nucleic acid molecule that is completely complementary to SEQ ID NO:5.
6. An isolated TSV diagnostic primer sequence consisting of SEQ ID NO:6 or an isolated nucleic acid molecule that is completely complementary to SEQ ID NO:6.
7. A pair of two different TSV diagnostic primer sequences wherein the TSV diagnostic primer sequences are selected from the group consisting of SEQ ID NOs:1-6 and the complete complementary sequences thereof; and the pair is capable of priming a nucleic acid amplification reaction that amplifies a region of nucleic acid within the TSV genome.
8. A pair of two different TSV diagnostic primer sequences according to claim 7 wherein the pair is selected from the group consisting of SEQ ID NOs:1 and 2, SEQ ID NOs:3 and 4, SEQ ID NOs:5 and 6, and SEQ ID NOs:3 and 6.
9. A kit for the detection of TSV comprising at least one pair of TSV diagnostic primer sequences of claim 7 .
10. A kit for the detection of TSV according to claim 9 wherein the kit further comprises at least one reagent selected from the group consisting of a reverse transcriptase, a thermostable polymerase, a mixture of four different deoxynucleotide triphosphates, a nucleic acid-binding fluorescent molecule, at least one pair of internal sample control primers, at least one internal template control and at least one pair of internal template control primers, and a probe comprising a complementary sequence to a portion of at least one region of nucleic acid within the TSV genome which is capable of being amplified with the at least one pair of TSV diagnostic primer sequences.
11. A method for detecting the presence of at least one TSV strain in a sample comprising:
(i) providing RNA from a sample suspected of containing TSV; and
(ii) probing the RNA with a probe selected from the group consisting of SEQ ID NOs:1, 2, 3, 4, 5, 6, 7, 8, 9, and the complete complimentary sequences thereof, under suitable hybridization conditions;
wherein the identification of a hybridizable nucleic acid fragment confirms the presence of at least one TSV strain.
12. A method according to claim 11 wherein the probe contains a replication inhibiting moiety at the 3′ end.
13. A method according to claim 12 wherein the replication inhibiting moiety is selected from the group consisting of dideoxynucleotides, 3′ deoxynucleotides, a sequence of mismatched nucleosides or nucleotides, 3′ phosphate groups and chemical agents.
14. A method according to claim 13 where in the 3′ deoxynucleotide is cordycepin.
15. A method for detecting the presence of at least one TSV strain in a sample comprising:
(i) providing RNA from a sample suspected of containing TSV;
(ii) synthesizing complementary DNA to said RNA using a reverse transcriptase and at least one TSV diagnostic primer sequence—as set forth in SEQ ID NOs: 1-6 or the complete complementary sequences thereof; and
(iii) amplifying said complementary DNA with at least one pair of two different TSV diagnostic primer sequences wherein the TSV diagnostic primer sequences are selected from the group consisting of SEQ ID NOs:1-6 and the complete complementary sequences thereof, such that amplification products are generated;
wherein the presence of amplification products confirms the presence of at least one TSV strain.
16. A method for detecting the presence of at least one TSV strain in a sample according to claim 15 wherein the amplifying of (iii) is done using the polymerase chain reaction.
17. A method for detecting the presence of at least one TSV strain in a sample according to claim 15 wherein the amplifying of (iii) is done in the presence of a nucleic acid-binding fluorescent agent or a fluorescently labeled probe and the presence of amplification products is confirmed using fluorescence detection.
18. A method according to claim 17 wherein the fluorescently labeled probe is selected from the group consisting of SEQ ID NO:14 and SEQ ID NO:15.
19. A method according to claim 15 wherein at least one pair of internal sample control primers is included in the amplifying of (iii) to produce an internal sample control product.
20. A method according to claim 19 wherein the at least one pair of internal sample control primers is selected from the group consisting of SEQ ID NOs:10 and 11 and SEQ ID NOs:12 and 13.
21. A method according to claim 15 wherein at least one pair of internal template control primers and at least one internal template control are included in the amplifying of (iii) to produce an internal template control product.
22. A method according to claim 15 , wherein the method further comprises the steps of:
a) treating an environment from which the sample was obtained with a chemical treatment to kill or control the TSV; and
b) repeating the steps (i) through (iii) on another sample taken from the environment in order to assess TSV inactivation by the chemical treatment.
23. A method for quantifying the amount of TSV in a sample comprising:
(i) providing RNA from a sample suspected of containing TSV;
(ii) synthesizing complementary DNA to said RNA using a reverse transcriptase and at least one TSV diagnostic primer sequence as set forth in SEQ ID NOs:1-6 or the complete complementary sequences thereof;
(iii) amplifying said complementary DNA with at least one pair of two different TSV diagnostic primer sequences, wherein the TSV diagnostic primer sequences are selected from the group consisting of SEQ ID NOs:1-6 and the complete complementary sequences thereof, by thermal cycling between at least a denaturing temperature and an extension temperature in the presence of a nucleic acid-binding fluorescent agent or a fluorescently labeled probe;
(iv) measuring the amount of fluorescence generated by the nucleic acid-binding fluorescent agent or the fluorescently labeled probe during the thermal cycling;
(v) determining a threshold cycle number at which the amount of fluorescence generated by the nucleic acid-binding fluorescent agent or the fluorescently labeled probe reaches a fixed threshold value above a baseline value; and
(vi) calculating the amount of TSV in the sample by comparing the threshold cycle number determined for the TSV in the sample with a standard curve of the threshold cycle number versus the logarithm of template concentration determined using standard solutions of known concentration.
24. A method according to claim 23 wherein the fluorescently labeled probe is selected from the group consisting of SEQ ID NO:14 and SEQ ID NO:15.
25. A method according to claim 23 wherein the method further comprises the steps of:
a) treating an environment from which the sample was obtained with a chemical treatment to kill or control the TSV; and
b) repeating the steps (i) through (vi) on another sample taken from the environment in order to assess TSV inactivation by the chemical treatment.
26. A method according to any of claim 15 or 23 wherein the method further comprises the step of: treating an environment from which the sample was obtained with a chemical treatment to kill or control the TSV in order to improve health and grow-out of shrimp.